INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
University Hospital of Geneva
Ginebra, SuizaPublicaciones en colaboración con investigadores/as de University Hospital of Geneva (21)
2024
-
Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
Transplantation and Cellular Therapy, Vol. 30, Núm. 1, pp. 93.e1-93.e12
-
Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study
JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387
2023
-
Unveiling the incidences and trends of the neglected zoonosis cystic echinococcosis in Europe: a systematic review from the MEmE project
The Lancet. Infectious diseases, Vol. 23, Núm. 3, pp. e95-e107
2022
2021
-
A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
Frontiers in Psychiatry, Vol. 12
-
Correction to: Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir (Infectious Diseases and Therapy, (2021), 10, 4, (2203-2222), 10.1007/s40121-021-00455-1)
Infectious Diseases and Therapy
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score
British Journal of Surgery, Vol. 19, Núm. 4
-
Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2203-2222
-
Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
Frontiers in Psychiatry, Vol. 12
2020
2018
-
Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO
Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380
2016
-
Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy
Journal of Medical Genetics, Vol. 53, Núm. 8, pp. 511-522
2013
-
Influence of body mass index on the association of weight changes with mortality in hemodialysis patients
Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733
2012
-
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/ Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Haematologica, Vol. 97, Núm. 2, pp. 310-317
-
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation
Leukemia, Vol. 26, Núm. 8, pp. 1821-1828
2011
-
Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats
Leukemia, Vol. 25, Núm. 9, pp. 1467-1470
2009
-
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: Identification of prognostic factors predicting outcome
Haematologica, Vol. 94, Núm. 2, pp. 230-238